J3370 – Injection, vancomycin hcl, 500 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ3370
- Long description
- Injection, vancomycin hcl, 500 mg
- Short description
- Vancomycin hcl injection
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 1986
- Last change
- July 1, 2025 – No change
- Termination date
- June 30, 2025
Frequently asked questions
What is HCPCS code J3370?
J3370 is a HCPCS Level II code for injection, vancomycin hcl, 500 mg. It was discontinued on June 30, 2025.
Does Medicare cover J3370?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J3320 – Injection, spectinomycin dihydrochloride, up to 2 gm
- J3350 – Injection, urea, up to 40 gm
- J3355 – Injection, urofollitropin, 75 iu
- J3357 – Ustekinumab, for subcutaneous injection, 1 mg
- J3358 – Ustekinumab, for intravenous injection, 1 mg
- J3360 – Injection, diazepam, up to 5 mg
- J3364 – Injection, urokinase, 5000 iu vial
- J3365 – Injection, iv, urokinase, 250,000 i.u. vial
- J3371 – Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg
- J3372 – Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg
- J3373 – Injection, vancomycin hydrochloride, 10 mg
- J3374 – Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg
- J3375 – Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
- J3376 – Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg
- J3379 – Injection, valproate sodium, 5 mg
- J3380 – Injection, vedolizumab, intravenous, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.